Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT07529782 · RECRUITING
Trial details
- NCT number
- NCT07529782
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-17
- Primary completion
- 2026-06-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.